Apr 18 |
The9 Full Year 2023 Earnings: CN¥40.61 loss per share (vs CN¥406 loss in FY 2022)
|
Apr 16 |
The9 Limited Achieved 66% Increase in Net Revenues and Turned Net Loss into Net Income for the Year Ended December 31, 2023
|
Apr 15 |
A New Generation of Antidepressant Drug Precision Treatment Based on Revolutionary AI Technology is Born
|
Mar 26 |
/C O R R E C T I O N -- The9 Limited/
|
Mar 26 |
The9 to further invest in WM Therapeutic
|
Mar 5 |
The9 Signed a Legally Binding Term Sheet to Acquire a Leading AIGC Driven Digital Human SaaS Platform ShenMa
|
Feb 21 |
The9 Signed a Legally Binding Term Sheet with a Leading AI SaaS Legal Service Platform 365LAWHELP.COM
|
Jan 19 |
China's The9 CEO to purchase no more than 10% of ADSs in open market
|
Jan 19 |
The9's Chairman and CEO to Purchase No More Than 10% of The9 ADSs in the Open Market
|
Nov 30 |
The9 Limited raises $12M in private placement transaction
|